These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20387993)

  • 21. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.
    Shah P; Chavda K; Vyas B; Patel S
    Drug Deliv Transl Res; 2021 Jun; 11(3):1166-1185. PubMed ID: 32804301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
    Hu L; Jia H; Luo Z; Liu C; Xing Q
    Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge.
    Velpula A; Jukanti R; Janga KY; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1895-906. PubMed ID: 22458264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.
    Hu X; Fan W; Yu Z; Lu Y; Qi J; Zhang J; Dong X; Zhao W; Wu W
    Nanoscale; 2016 Apr; 8(13):7024-35. PubMed ID: 26725649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release mechanism studies on TFu nanoparticles-in-microparticles system.
    Sun W; Zhang N; Li X
    Colloids Surf B Biointerfaces; 2012 Jun; 95():115-20. PubMed ID: 22424827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles.
    Yu Z; Fan W; Wang L; Qi J; Lu Y; Wu W
    Mol Pharm; 2019 Dec; 16(12):5013-5024. PubMed ID: 31638827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved delivery of cromolyn from oral proliposomal beads.
    Deshmukh DD; Ravis WR; Betageri GV
    Int J Pharm; 2008 Jun; 358(1-2):128-36. PubMed ID: 18400424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity.
    Yang T; Sheng HH; Feng NP; Wei H; Wang ZT; Wang CH
    J Pharm Sci; 2013 Dec; 102(12):4414-25. PubMed ID: 24166599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.
    Gupta Y; Jain A; Jain SK
    J Pharm Pharmacol; 2007 Jul; 59(7):935-40. PubMed ID: 17637187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
    Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
    J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendrimer grafts for delivery of 5-fluorouracil.
    Tripathi PK; Khopade AJ; Nagaich S; Shrivastava S; Jain S; Jain NK
    Pharmazie; 2002 Apr; 57(4):261-4. PubMed ID: 11998447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
    Liu J; Li X; Cheng YN; Cui SX; Chen MH; Xu WF; Tian ZG; Makuuchi M; Tang W; Qu XJ
    Eur J Pharmacol; 2007 Nov; 574(1):1-7. PubMed ID: 17904544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.